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Abstract Most Trichoderma reesei cellulases consist of a 
catalytic and a cellulose binding domain (CBD) joined by a 
linker. We have used cellohexaose as a model compound for the 
glucose chain to investigate the interaction between the soluble 
enzyme and cellulose. The binding of cellohexaose to family I 
CBDs was studied by NMR spectroscopy. CBDs cause line 
broadening effects and decreasing T2 relaxation times for certain 
cellohexaose resonances, whereas there are no effects in the 
presence of a mutant which binds weakly to cellulose. Yet it 
remains uncertain how well the soluble cellooligosaccharide 
mimics the binding of CBD to the cellulose. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Cellulose has an environmental impact in the preservation 
of the global carbon cycle and a significant commercial po-
tential as a raw material for many industrial processes. For 
these reasons it is important to understand the biodégradation 
of crystalline cellulose on the molecular level, i.e. to relate 3D 
structures of cellulolytic enzymes and cellulose with activity. 
In nature Trichoderma reesei secretes cellulases which effi-
ciently hydrolyse crystalline cellulose. These enzymes have a 
large catalytic domain and a small cellulose binding domain 
(CBD), which is responsible for most of the affinity of the 
enzyme towards cellulose. The removal of the C B D has no 
effect on the capacity of the catalytic domain to hydrolyse 
small soluble cellooligosaccharides [1-6]. 
The CBDs of T. reesei cellulases share over 70% of amino 
acid sequence similarity and their 3D structures are very sim-
ilar too. The structures of C B D C B H I and three of its analogous 
peptides (Y5A, Y31A, Y32A) have been determined by N M R 
spectroscopy [7,8]. The structures of C B D C B H I I and C B D E ^ 
have been modelled based on the structure of C B D C B H I [9]. 
The preliminary N M R structure of C B D E Q I (our unpublished 
data) confirms that the model of C B D E G I is correct. In pro-
tein-carbohydrate interactions the presence of tyrosine or oth-
er aromatic residues at the binding face is common [10]. Ac-
cording to the 3D structures family I CBDs have exposed 
aromatic side-chains on one face of the domain. The spacing 
and alignment of the aromatic rings and the adjacent gluta-
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CBDCBHI where tyrosine 31 is replaced by alanine 
mines and asparagines with amide groups are such that multi-
ple interactions with the glucose units on the cellulose crystal 
are conceivable [5,6,8,11]. 
In the present work the binding of cellohexaose to CBDs 
from T. reesei cellulases (CBHI, CBHII , EGI) and to one 
mutan t of C B D C B H I (Y31A) has been investigated by : H -
N M R spectroscopy. Cellohexaose is the longest readily avail-
able cellooligosaccharide which can be used to mimic the glu-
cose chain of cellulose. Cellooligosaccharides longer than cel-
lohexaose have limited solubility in aqueous buffers. 
2. Materials and methods 
2.1. Cellohexaose and peptides 
The concentrated cellohexaose (Seikagaku Corp., USA) solution 
was prepared at pH 5 in D2O. The adsorption of CBD to cellulose 
is strongest at this pH [6]. The concentration of the soluble cellohex-
aose was about 0.35 mM. NaN3 (0.02%) was added as an antimicro-
bial agent. 
CBDCBHI was cloned and produced in E. coli [12]. Y31A was syn-
thesised by automated solid-phase synthesis using Fmoc chemistry 
and purified as described earlier [13]. The primary structures of the 
peptides were confirmed by amino acid analysis and mass spectrom-
etry. The peptide concentration in the cellohexaose solution at the end 
of titration was about 250 uM for CBDCBHI and Y31A. 
2.2. NMR experiments 
The cellohexaose solution (300 ul) was pipetted into a Shigemi 
NMR tube and the ID 'H-NMR spectrum of the pure cellooligosac-
charide was recorded. Then the peptide was added in 5 ul and 10 ul 
volumes to obtain titration plots. For the binding constant (A"d) de-
termination the titration was also performed in two constant 
CBDCBHI concentrations by adding known amounts of cellohexaose. 
The NMR spectra were acquired with a Varian UNITY 600 Spec-
trometer. The high field provided with a sufficient resolution for the 
resonances of the cellooligosaccharide. The digitally filtered spectral 
width was 8000 Hz, the acquisition time 1.0 s, the 45° pulse 5 |is, and 
the repetition time 4.0 s. For each spectrum 128 transients were col-
lected. The chemical shifts at 5°C are relative to residual Ff20 at 4.85 
ppm. 
The spectra were deconvoluted into individual Lorentzian lines to 
determine the full linewidth at half-height. The complete calculated 
spectrum and each of its individual components were compared with 
the measured spectrum. Spectra for T2 analysis were acquired with the 
CPMG pulse sequence. The 2D NOESY spectrum of the pure cello-
hexaose and the solution corresponding the highest CBDCBHI concen-
tration in cellohexaose were recorded with standard pulse sequences 
and phase cycling [14] with a 500 ms mixing time. All experiments 
were performed at 5 and 20°C. 
3. Results 
The resonances of the cellohexaose broadened when 
C B D C B H I was added into the solution (Fig. 1). Increasing 
amounts of the peptide caused progressively larger line broad-
ening (Fig. 2), but the chemical shifts of the cellooligosacchar-
ide protons were not affected by the additions of CBD. There-
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Fig. 1. ID 'H-NMR spectra of cellohexaose, pure and in the presence of CBDs (CBHI, EGI, and Y31A) at 5°C. Resonance assignments are 
according to Ikura and Hikichi [30]. The ratio of cellohexaose to CBD is 2:1 for CBDCBHI and Y31A. For CBDEGI the ratio is 3:1. 
fore, the free and bound cellohexaose were in a fast exchange. 
The line broadening phenomenon (Fig. 1) was observed also 
for CBDs of CBHII (not shown) and EGI, but not for a 
mutant of CBDCBHI (Y31A) which was previously shown to 
bind only very weakly to cellulose [11]. The pure amino acids 
(tyrosine and tryptophan) which were employed as controls 
did not cause any line broadening effects (not shown). A de-
tailed comparison of the cellohexaose spectra acquired in the 
presence of different CBDs with the spectrum of the pure 
cellohexaose revealed, that the line broadening effects were 
most significant for the a lß protons in the reducing end of 
the cellohexaose and for the internal and terminal 1 protons 
(bl, cl , dl , el, fl). The line broadening effects were also seen 
in the spectral region of the 3, 4, and 5 protons. Because the 
lines of these protons overlap in the spectrum of the pure 
cellohexaose, it was impossible to identify unambiguously 
which protons caused the line broadening effects in the pres-
ence of CBD. For CBDCBHI and Y31A these effects were 
studied as a function of peptide concentration at 5 and 20°C. 
In the case of CBDCBHI the largest line broadening effects 
were seen for the terminal 1 protons (Fig. 2D). The difference 
between the linewidths corresponding to the highest peptide 
concentration and the starting point, where no CBD was 
added, was 9 Hz at 5°C and 6 Hz at 20°C. The broadening 
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Fig. 2. A series of spectral regions of protons 3, 4, and 5 for (A) CBDCBHI and (B) Y31A acquired at 5°C. Linewidths (Avi/2) of certain cello-
hexaose protons as a function of peptide (CBDCBHI, Y31A) concentration: (C) ala ( A ) and alß (0) ; (D) bl, cl, dl, el ( A ) and fl (0) ; (E) 
6 ( A ) and 6' (0) ; (F) 2 ( A ) . Solid symbols correspond to experiments at 5°C and open symbols at 20°C. Lines are guides to the eye. 
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Fig. 3. NOESY spectrum of cellohexaose in the presence of CBDCBHI at 5°C. In the insets certain cross peaks of the cellooligosaccharide are 
compared with the NOEs obtained from the pure cellohexaose solution using the same experimental conditions. Pure cellohexaose is shown on 
the right (A and B) and below (C) the insets. 
was obvious also for alß protons (Fig. 2C). These linewidths 
increased more than 6 Hz at 5°C and about half of that at 
20°C. The increase in the linewidth was linear up to 75 uM 
peptide concentration at both temperatures. For internal 1 
protons (Fig. 2D) the effect was of the same order of magni-
tude as for alß protons. Also the linewidths of protons 3, 4, 
and 5 increased, but this spectral region (3.45-3.55 ppm) was 
too crowded to be interpreted specifically. Therefore, only a 
series of spectral expansions in this region is shown as a func-
tion of peptide concentration (Fig. 2A). For proton 2 (Fig. 
2F) the increase in the linewidths was about 3 Hz at 5°C and 
less than 2 Hz at 20°C. For protons 6 and 6' (Fig. 2E) the 
linewidths broadened less than 2 Hz at both temperatures. No 
line broadening effects were observed for a l a protons (Fig. 
2C) in the reducing end of the cellohexaose as a function of 
peptide concentration at either temperatures. From the cello-
hexaose titration experiments at constant CBD concentrations 
the equilibrium binding constant (Äj) was calculated to be 
350 ±90 uM for CBDCBHI at 5°C [15]. The accuracy was 
limited by the resolution of spectra. For CBDCBHII and 
CBDEGI the binding constants were comparable with Kd of 
CBDCBHI-
The same experiments were repeated for the Y31A mutant 
of CBDCBHI (Fig. 2). No line broadening effects were observed 
for any of the well resolved cellohexaose resonances. At both 
temperatures the error of linewidths was at most 1 Hz. For 
the spectral region of protons 3, 4, and 5 no line broadening 
effects were observed at high concentrations of Y31A. How-
ever, small changes in the spectral appearance were caused by 
the lines of Y31A. 
Ti relaxation measurements confirmed the linewidth meas-
urements. The effects were observed for all native CBDs but 
not for Y31A. Ti rates decreased for alß, internal and termi-
nal 1 protons on an average to a third of the values of pure 
cellohexaose. T2 analysis could not be performed for the res-
onances of 3, 4, and 5 protons due to the overlap of these 
lines. 
Transferred NOE experiments carried out at 5°C for the 
solution corresponding to the highest CBDCBHI concentration 
in cellohexaose (Fig. 3) revealed broadened cross peaks for 
cellohexaose protons, as expected based on the ID measure-
ments. Also for CBDCBHI some cross peaks, for example be-
tween ring protons of tyrosines, were observed. However, no 
unambiguous cross peaks between the cellohexaose protons 
and the ring protons of tyrosines were seen. 
We demonstrated that the line broadening effects disappear 
by adding CBHII enzyme into mixtures of CBD and cellohex-
aose to produce these degradation products of cellohexaose 
(data not shown). As a consequence all resonances of the 
cellooligosaccharides narrowed and were equally narrow as 
recorded from a reference sample. Simultaneously, the inten-
sity of the lines of the terminal (fl) and reducing end (al) 
protons increased and correspondingly the intensity of the 
lines of the internal protons decreased. Consequently, we con-
clude that CBDCBHI and CBDEGI do not bind to short soluble 
cellooligosaccharides like cellotriose and cellobiose. 
4. Discussion 
So far there is no unambiguously proven model at the res-
M.-L. Mattinen et al. IFEBS Letters 407 (1997) 291-296 295 
CBD CBHI 
CBD EGI 
Y31A 
Fig. 4. Binding model. Wild type CBDs (CBHI, EGI) and an engineered peptide of CBDCBHI (Y31A) are positioned on the glucose chain (only 
six glucose units are drawn) with aromatic rings stacked on top of rings. Only the aromatic residues (Y5, Y32, Y31, Y33, W6), glutamines 
(Q34, Q35), asparagines (N29, N30) and mutated residue (A31) are shown. 
idue level of how CBD interacts with crystalline cellulose and 
if it can act as a molecular unzipper of the cellulose chains [6]. 
Although the 3D structures of certain fungal CBDs are 
known, studies of the interaction are at least partly compli-
cated by the complex structure of cellulose. 
The 3D structure of crystalline cellulose has been studied 
intensively with different methods during several years [16-
18]. Recently molecular modelling in combination with atomic 
force microscopy (AMF) techniques has been used to analyse 
cellulose surfaces [19]. Cellulose is composed of parallel linear 
polymeric chains of glucose, which pack together by regular 
hydrogen bonding networks. The glucose monomers are 
joined by ß-1,4 linkages which create a two-fold screw axis 
along the polymer. Therefore, the repeating unit is a cello-
biose. In addition to the crystalline regions there are crystal 
defects, dislocations, chain ends, twists, etc., and amorphous 
regions, which may be initial target sites for cellulases [20]. 
According to several investigations family I CBDs (CBHI, 
CBHII and EGI) bind to cellulose via their flat face [5,6,11]. 
Adsorption measurements in combination with structural 
analyses of several mutated CBDs of CBHI have lead to the 
conclusion that the residues Y5, Y31, Y32 and Q34 at the flat 
face are functionally important. Particularly the number of 
aromatic residues and their precise spatial arrangement are 
critical for the specific binding [8,21]. In CBDCBHI the rough 
face is not directly involved in the function of the CBD [6,11]. 
The four side-chains at the flat face of CBDCBHI (Y5, Y31, 
Y32, Q34) and CBDEGi (W6, Y32, Y33, Q35) can be aligned 
along the cellulose chain (Fig. 4). For CBDCBHI the alignment 
is within the precision of the structures [7]. A similar align-
ment is obtained for C B D E Q I . For the Y31A mutant of 
CBDCBHI residues Y5, N29, Y32, and Q34 are along the 
same line at the flat face. A31 is slightly above and to the 
side of this alignment, where it should not interfere with the 
weak but observed binding to the crystalline cellulose. These 
observations suggest a model of the binding in which the three 
aligned aromatic rings stack on every other glucose unit of the 
cellulose polymer. In the cellulose crystal form I, which occurs 
in nature, this surface is at the obtuse corner [22]. 
The planar polar amides of the glutamines and asparagines 
and hydroxyls of the tyrosines are potential for hydrogen 
bonding with oxygens of glucose. The amides that are off 
the alignment may assist in the inter polymer hydrogen 
bond breaking. Such a face-to-face stacking of aromatic res-
idues with glucose and extensive hydrogen bonding of polar 
groups with cellooligosaccharide hydroxyls have been ob-
served in several protein-carbohydrate interactions [23]. Hy-
drophobie effects have been found to primarily mediate inter-
actions between cellulose and family IV CBD [24]. 
The line broadening effects and decreasing T% relaxation 
times of cellohexaose resonances in the presence of native 
CBDs (CBHI, CBHII and EGI) suggest that cellohexaose 
may serve at least to some extent as a model compound to 
mimic the CBD-cellulose interaction. The binding is specific 
because no effects were observed for the Y31A mutant and for 
the reference compounds (tyrosine and tryptophan). Further-
more, the short cellooligosaccharides cellobiose and cellotriose 
do not qualify as model compounds. Consistent with the cel-
lulose structure where there is no oc-glycosidic bond the 
broadening of the alct line is negligible. Curiously, the line 
broadening effects for 1, 3, and 5 protons of cellohexaose are 
substantially larger than that of the 2, 6 and 6' protons. The 
line broadening effects of proton 4 cannot be distinguished 
from the overlapping lines of protons 3 and 5. Concerning 
the binding model, presented above, it is conceivable that 
the aromatic rings could preferably align with the hydropho-
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bic patches of C l , C3, and C5 of glucose which are larger 
than the patches of C2 and C4. However, the specific proof 
for the binding model remains to be obtained, because no 
unambiguous transferred N O E s were observed between the 
C B D and the cellohexaose. Since the line broadening effects 
decreased with increasing temperature it was not possible to 
choose a temperature high enough, so the cross peaks of the 
free cellohexaose vanish [15]. 
We find the observations for cellohexaose-CBD binding 
somewhat contradict the cellulose-CBD binding. The affinity 
of the native CBDs towards cellulose follows the order 
C B D C B H I ~ C B D C B H I I < C B D E G I [11,12], but the results with 
cellohexaose indicate no significant difference between the 
CBDs. The discrepancies between the results of the soluble 
model compound and native solid substrate may arise from 
several sources. The flat face of C B D C B H I differs from that of 
C B D C B H I I and C B D E G I which have t ryptophan in the position 
5 instead of tyrosine. Therefore, the periodicity of the aro-
matic rings of C B D C B H I I and C B D E G : do not match the hy-
drophobic patches of the cellooligosaccharide as well as in the 
case of C B D C B H I -
Recently published data with family II CBD, which adsorbs 
to both crystalline and amorphous cellulose [25,26], support 
the role of the t ryptophan residues in cellooligosaccharide 
binding, but the interactions are weak. The results with family 
IV CBD, which binds solely to amorphous cellulose, reveal 
that tyrosines rather than t ryptophans are involved in the 
cellooligosaccharide binding [27]. The binding face of one 
family IV C B D is concave forming a cleft into which the 
cellooligosaccharide chains, but not crystalline cellulose, can 
penetrate [28]. For the family IV C B D the structure of the 
binding site is clearly different from that of CBDs belonging 
to families I and II, which have three aligned aromatic side-
chains on the binding face [7,25]. For the family III CBDs the 
residues which interact with cellulose are unknown and there 
is no proof for the specific binding to short cellooligomers 
[29]. 
The flexible soluble oligosaccharide fails to provide a dis-
tinct rigid surface, where the family I C B D could attach. The 
strong and specific binding of C B D to the flat and rigid sur-
face of crystalline cellulose rather than to the soluble and 
flexible cellooligosaccharide polymer to be hydrolysed by the 
core domain is, of course, precisely how the C B D may assist 
in the breakdown of crystalline cellulose. 
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